Y-shaped pegylated growth hormone injection (YPEG-rhGH) / Xiamen Amoytop Biotech - LARVOL DELTA

Population pharmacokinetics/pharmacodynamics and safety of YPEG-rhGH in elderly subjects. (PubMed, Front Pharmacol) - "The safety and tolerability of YPEG-rhGH injections in elderly subjects were favorable. Clinical Trial Registration: identifier CTR20230176."

Clinical • Journal • PK/PD data • Endocrine Disorders • Growth Hormone Deficiency • Growth Hormone Deficiency (Adult) • IGF1

A Trial of YPEG-rhGH in Children With Short Stature (clinicaltrials.gov) - P2 | N=78 | Completed | Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Active, not recruiting ➔ Completed

Trial completion • Genetic Disorders • Idiopathic Short Stature • Small for Gestational Age • Turners Syndrome